QBE Europe’s Post

Read the latest report by QBE, where we delve into AI usage in the life sciences sector.

QBE is thrilled to present our latest resilience series report, this time focusing on AI in the life sciences sector. The integration of artificial intelligence and other cutting-edge technologies is poised to revolutionize the healthcare industry in many ways. Our report explores this trend in detail, highlighting the emerging risks, growth areas, and implications for insurance. Read the report here - https://lnkd.in/eYCdDeuv #lifescience #pharmaceuticals #insurancebroker

Explore the future of pharma research. Uncover the profound influence of AI and Data Analytics in reshaping drug development and healthcare solutions. https://ow.ly/asmr50QnhV6 #DigitalSuccess #Growth #AIinPharma #DataAnalytics

🚀 Embracing Pharma 4.0: Revolutionizing the Future of Pharmaceutical Manufacturing 🌐💊 Pharma 4.0 is reshaping the landscape of pharmaceutical manufacturing, propelling the industry into a new era of innovation and efficiency. By integrating digital technologies like IoT, AI, and big data analytics, Pharma 4.0 promises to streamline production processes, enhance product quality, and accelerate drug development timelines.

🚀 𝐄𝐦𝐛𝐫𝐚𝐜𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞: 𝐓𝐨𝐩 𝟏𝟎 𝐏𝐡𝐚𝐫𝐦𝐚 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝟐𝟎𝟐𝟒! 🌐 The pharmaceutical landscape is undergoing a revolutionary transformation, driven by cutting-edge technologies ⭐ Here are the game-changing trends shaping the industry in 2024: AI & automation, extended reality, big data analytics, outsourcing drug manufacturing, precision medicine, and more. Which trend excites you the most? Share your thoughts in the comments below and let's discuss the future of the pharma industry! #PharmaTrends #2024Outlook

𝐓𝐡𝐞 𝐏𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐨𝐟 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐀𝐈/𝐌𝐋 𝐢𝐧 𝐂𝐚𝐮𝐬𝐚𝐥𝐢𝐭𝐲 𝐀𝐬𝐬𝐞𝐬𝐬𝐦𝐞𝐧𝐭 𝐟𝐨𝐫 𝐒𝐚𝐟𝐞𝐭𝐲 𝐕𝐢𝐠𝐢𝐥𝐚𝐧𝐜𝐞 Causality assessment is pivotal in safety vigilance, linking drugs to adverse events. Traditionally, this has been a manual task, but automation through AI/ML is revolutionizing this space. Our latest article by Josipa Ljubičić Proqlea Ltd. and Ryanka Chauhan Datafoundry delves into how AI and ML models are transforming causality assessment, enhancing signal detection, evidence strength, and benefit-risk evaluations. 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐚𝐧𝐝 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐜𝐨𝐦𝐞 𝐰𝐢𝐭𝐡 𝐢𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐢𝐧𝐠 𝐀𝐈 𝐚𝐧𝐝 𝐌𝐋 𝐢𝐧𝐭𝐨 𝐬𝐚𝐟𝐞𝐭𝐲 𝐯𝐢𝐠𝐢𝐥𝐚𝐧𝐜𝐞 𝐚𝐧𝐝 𝐡𝐨𝐰 𝐢𝐭 𝐜𝐚𝐧 𝐫𝐞𝐝𝐞𝐟𝐢𝐧𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐬𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐬. https://lnkd.in/gzCF3Cnt #AI #MachineLearning #Pharma #SafetyVigilance #DrugSafety #CausalityAssessment #Automation #Innovation #Healthcare #Pharmaceuticals #DataScience #RiskManagement #FutureOfMedicine #TechInPharma #AIinHealthcare

Let's talk about the complementary relationship between AI and human intelligence. While AI can perform certain tasks efficiently, human intelligence provides the critical thinking and adaptability necessary for complex decision-making and innovation. In the context of compliance in the pharmaceutical and medical device industry, AI can: ☑️ assist in data analysis and risk assessment, but human expertise is essential for interpretation and decision-making. ☑️ streamline processes like regulatory reporting, but human validation ensures accuracy and completeness. ☑️ inform continuous improvement, but human innovation drives strategy and adaptation to evolving regulations and standards. Ultimately, combining AI as a supportive tool with human intelligence enables organizations to optimize compliance efforts while maintaining focus on regulatory adherence and patient safety. 𝗗𝗼 𝘆𝗼𝘂 𝗮𝗴𝗿𝗲𝗲? Let us know what you think in the comments below! #GMP #pharmaceuticals #medicaldevices #biotech #AI #QMS

🔍 Curious about 𝐡𝐨𝐰 𝐭𝐡𝐞 𝐄𝐔 𝐀𝐈 𝐀𝐜𝐭 𝐰𝐢𝐥𝐥 𝐫𝐞𝐬𝐡𝐚𝐩𝐞 𝐭𝐡𝐞 𝐩𝐡𝐚𝐫𝐦𝐚 𝐚𝐧𝐝 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐬𝐞𝐜𝐭𝐨𝐫𝐬? Discover our comprehensive guide that: ◾ Delves into the EU AI Act ◾ Provides an implementation timeline ◾ Examines the impact on pharma and healthcare ◾ Outlines challenges and preparations needed Additionally, explore our latest report, '𝐔𝐧𝐥𝐨𝐜𝐤𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚: 𝐇𝐨𝐰 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐬 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐭𝐡𝐞 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲.' Uncover exciting opportunities within the pharma value chain. Download the report here. Join us at 𝐏𝐡𝐚𝐫𝐦𝐚 𝐈𝐐'𝐬 𝐀𝐈 𝐟𝐨𝐫 𝐏𝐡𝐚𝐫𝐦𝐚 & 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐒𝐮𝐦𝐦𝐢𝐭 (𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝟐𝟒-𝟐𝟔, 𝟐𝟎𝟐𝟒, 𝐀𝐦𝐬𝐭𝐞𝐫𝐝𝐚𝐦). Learn from industry leaders about AI implementation in drug development, clinical trials, and supply chain/manufacturing. 🚀 𝐋𝐞𝐚𝐝 𝐭𝐡𝐞 𝐀𝐈 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐩𝐡𝐚𝐫𝐦𝐚 𝐚𝐧𝐝 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞: https://lnkd.in/gjui2n_8 #EUAIACT #Pharma #Healthcare #AI #ArtificialIntelligence #PharmaInnovation #ClinicalTrials #DrugDevelopment #SupplyChain #Manufacturing #PharmaSummit #HealthcareInnovation #AIinPharma #AIinHealthcare

Reducing risks and meeting regulatory standards are non-negotiable in AI implementation for industries like healthcare, pharmaceuticals, and financial services. Discover how to establish robust protocols to safeguard against potential pitfalls. Check out our blog post 👉 https://hubs.la/Q02nCTv70 #AI #BestPractices #RegulatoryCompliance

Our digital health experts, Lauren (Jensen) Horn, Ph.D. and Alexandria K., recently attended the 2023 AI Summit, and sat down on The Factor to share the key insights that are shaping the future of AI. Watch now: https://lnkd.in/ek9n5yW3 The conversation reviews various presentations by industry professionals from CDRH, FDA, the Coalition of Health, and other influential organizations and individuals in this field. They discuss the application of SHAP values, underscore the significance of transparency, and address the impacts of bias. Moreover, they highlight the crucial role of stakeholder involvement in ensuring a strategic and purposeful integration of AI. #healthcare #ai #machinelearning #artificialintelligence #humanfactors #lifescience #medicaldevices #pharmaceutical